Results 101 to 110 of about 20,221 (204)

Rare but relevant: Ibogaine and cardiovascular complications—prolonged QT interval and ventricular arrhythmias

Addiction, Volume 121, Issue 6, Page 1616-1621, June 2026.
Abstract Revived interest in psychedelic‐assisted therapies has also renewed focus on ibogaine, a psychoactive alkaloid, for its notable anti‐addictive potential. Evidence from observational, open‐label, and limited randomized placebo‐controlled trials indicates that ibogaine and its metabolite noribogaine reduce craving and withdrawal symptoms in ...
Tibor Markus Brunt
wiley   +1 more source

Huntington's Disease and Criminal Behaviour: An Exploration of Psychiatric Risk and Management in a High Secure Forensic Unit

BJPsych Open
Aims Huntington’s disease (HD) is an autosomal dominant neurodegenerative disorder characterised by a pathologically prolonged CAG nucleotide sequence in the huntingtin gene (HTT).
Thomas Gupta-Jessop, Ellice Caldwell-Dunn   +1 more
doaj   +1 more source

Psychopharmacology 2003 Conference, 10-13 September 2003

South African Journal of Psychiatry, 2003
List of abstracts and authors: 1. Comparative benefits of Atypical antipsychotics Diana P Morrison 2. Evidence-based management of depression in Schizophrenia Andre F Joubert 3. Second generation Antipsychotics: An African update Dave Swingler 4.
Diana P Morrison, Andre F Joubert, Dave Swingler, Denise White, Joseph R Calabrese, Roger M Pinder, Donald W Black, David R Williams, David Castle, Dora Wynchank, Kerry Gibson, Helen Clark, Greg McCarthy, Alan J Flisher, Sebastian Akalula, James Warwick, Theophilus Lazarus, Frans Korb, Nandi Siegfried, Z Nthakwana, Petro Kempen, Eugene Allers, Alan St Clair Gibson, Mark Solms, Ruth Jarvis, Edward Nyatia, Joachim Uys, Amichand Dairam, H Maharaj, M Mabanda, Joseph R Calabrese   +30 more
doaj   +1 more source

The association between autism and psychosis and the tools used to measure it: An updated systematic review and meta‐analysis

British Journal of Clinical Psychology, Volume 65, Issue 2, Page 374-400, June 2026.
Abstract Objectives Autistic individuals are at increased risk of psychotic experiences and being diagnosed with psychotic disorders. This association may result from methodological issues, including the misinterpretation of psychosis questionnaires by autistic individuals and clinicians' difficulty distinguishing between the conditions.
Michael R. Miles, Dennis Golm, Emma Palmer‐Cooper   +2 more
wiley   +1 more source

Delírio de infestação parasitária e folie à deux: relato de caso Delusional parasitic and folie à deux: case report

Arquivos de Neuro-Psiquiatria, 2003
Quadros de transtorno psiquiátrico induzido (folie à deux) são raros. Porém, sua prevalência pode ser de 5-25% nos casos de delírio de infestação parasitária.
Quirino Cordeiro Júnior, Carlos Eduardo Pereira Corbett   +1 more
doaj   +1 more source

Epistemic authenticity

Noûs, Volume 60, Issue 2, Page 413-432, June 2026.
Abstract There are better and worse ways to acquire epistemic virtues and more generally to be disposed to change or maintain one's epistemic dispositions over time. This is a dimension along which one might be better or worse as an epistemic agent that, we argue, cannot be explained with reference to current normative categories in epistemology but ...
Laura Frances Callahan, Michael C. Rea
wiley   +1 more source

Psychotic Symptoms Following Subthalamic DBS in Parkinson's Disease: Three Clinical Cases and Literature Review

Clinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT Psychosis may emerge after subthalamic deep brain stimulation in Parkinson's disease, regardless of prior psychiatric history. Early recognition of stimulation‐related behavioral changes, careful dopaminergic adjustment, and multidisciplinary postoperative monitoring are essential to differentiate DBS‐induced psychotic symptoms from disease ...
Saeed Abdollahifard, Raziyeh Rezaei, Erfan Sanaei, Fatemeh Asadi, Amirmohammad Farrokhi, Malihe Mehdinejad Haghighi, Fatemeh Khademi, Sina Sabet, Aliasghar Karimi, Ali Razmkon, Nematollah Jaafari   +10 more
wiley   +1 more source

The Effect of Iclepertin on Hematological Parameters: An Overview of Nonclinical Studies and Clinical Trials in Healthy Volunteers and Patients with Cognitive Impairment Associated with Schizophrenia

The Journal of Clinical Pharmacology, Volume 66, Issue 5, May 2026.
Abstract There are currently no approved pharmacotherapies to treat cognitive impairment associated with schizophrenia (CIAS). Iclepertin (BI 425809) is a selective glycine transporter‐1 (GlyT1) inhibitor that was investigated for the treatment of CIAS.
Peter Nagy, Justin Corey Fowler, Holger Rosenbrock, Wenbo Tang, Eric Fu, Annie Fraser, Holly Dursema, Julia Schlichtiger, Michael Desch, Fredrik Gruenenfelder   +9 more
wiley   +1 more source

Profile of inpatients with psychotic disorders referred to the consultation–liaison psychiatry unit in a general hospital in South India

Telangana Journal of Psychiatry
Context: Psychotic symptoms in patients with medical illnesses have been overlooked and have been understudied. It is important to understand the profile of such patients to facilitate early identification by the treating clinicians and to initiate ...
Kathleen Anne Mathew, Sharon Paul Methala, Arya Jith, Rahul Bansal   +3 more
doaj   +1 more source

MELAS‐Like Mitochondrial Encephalopathy With Catatonia Associated With a Pathogenic MT‐ND3 (m.10158 T > C) Mutation: A Case Report and Literature Review

Progress in Neurology and Psychiatry, Volume 30, Issue 2, May 2026.
Abstract Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke‐like episodes (MELAS) is a rare multisystem mitochondrial disorder primarily caused by mutations in mitochondrial DNA. While it typically presents with stroke‐like episodes, seizures, and lactic acidosis, recent evidence highlights a broader clinical spectrum, including ...
Faezeh Khorshidian, Vajiheh Aghamollaii, Mohammadreza Mousavipour, Setareh Rassa   +3 more
wiley   +1 more source